Evidence map›Paper›PMID 42294409›Full record

ArticleAdvances in radiation oncology2026

Time Course and Determinants of Acute Dysgeusia in Patients Receiving Head and Neck Radiation Therapy.

Sreenija Yarlagadda, Arun Maharaj, Tiffany Nong, Andrea V Gonzalez, Naima-Sajoni C Guerra, Dylan M Paterniti-Ruscin, Elysse Castro-Hall, Nicolas Carvallo, Lorein Gonzalez, Muni Rubens and 2 more

Abstract read
In one paragraph

Article in Advances in radiation oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Sreenija YarlagaddaMiami Cancer Institute, Baptist Health South Florida, Miami, Florida.
Arun MaharajMiami Cancer Institute, Baptist Health South Florida, Miami, Florida.
Tiffany NongMiami Cancer Institute, Baptist Health South Florida, Miami, Florida.
Andrea V GonzalezMiami Cancer Institute, Baptist Health South Florida, Miami, Florida.
Naima-Sajoni C GuerraMiami Cancer Institute, Baptist Health South Florida, Miami, Florida.
Dylan M Paterniti-RuscinMiami Cancer Institute, Baptist Health South Florida, Miami, Florida.
Elysse Castro-HallMiami Cancer Institute, Baptist Health South Florida, Miami, Florida.
Nicolas CarvalloMiami Cancer Institute, Baptist Health South Florida, Miami, Florida.
Lorein GonzalezMiami Cancer Institute, Baptist Health South Florida, Miami, Florida.
Muni RubensMiami Cancer Institute, Baptist Health South Florida, Miami, Florida.
Adeel KaiserMiami Cancer Institute, Baptist Health South Florida, Miami, Florida.
Noah S KalmanMiami Cancer Institute, Baptist Health South Florida, Miami, Florida.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: Dysgeusia is a common toxicity experienced by patients with head and neck cancer (HNC) receiving radiation therapy (RT). In this study, we assessed the timescale of onset, progression, and recovery of dysgeusia using an objective measure. Methods and Materials: Patients receiving RT for HNC to ≥ 50 Gy were included in this prospective observational study. The Waterless Empirical Taste Test (WETT) was used to objectively measure dysgeusia for the 5 basic tastes: sweet, sour, salty, bitter, and umami. Patients were assessed at baseline (pre-RT), 2 and 4 weeks mid-treatment, end of treatment (EOT), and 12 weeks post-RT. Changes in scores at different time points relative to baseline scores were computed. The significance of trends over time was tested using linear regression. Associations of taste scores with clinical and dosimetric variables were tested using Pearson correlation. Results: Of the 50 patients who underwent baseline taste testing, 32 completed 12-week post-RT follow-up assessments. The most common primary tumor site was the oropharynx (66%). The median WETT scores were 20.7 at baseline, 16.2 at 2 weeks, 17.7 at 4 weeks, 17.1 at EOT, and 19 at follow-up. Baseline and EOT comparisons revealed a decline in total score (-17.3%), with the highest relative changes in umami (-62.5%) and salty (-30.9%). The relative total score change between baseline and follow-up was -8.2% ( Conclusions: This study confirms significant alterations in taste perception in patients with HNC during/after RT. Taste changes correlated with mean tongue and oral cavity doses. Future studies and longer follow-up are warranted to define dose-response relationships in dysgeusia.

Identifiers

PMID42294409
PMCPMC13263620

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.